Fri, September 20, 2024
Thu, September 19, 2024
Wed, September 18, 2024
Tue, September 17, 2024
Mon, September 16, 2024
Fri, September 13, 2024

Derek Archila Maintained (ASND) at Buy with Increased Target to $289 on, Sep 17th, 2024


//stocks-investing.news-articles.net/content/202 .. th-increased-target-to-289-on-sep-17th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Derek Archila of Wells Fargo, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $264 to $289 on, Sep 17th, 2024.

Derek has made no other calls on ASND in the last 4 months.



There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 0 agree with Derek's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Derek


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $170 on, Monday, September 16th, 2024
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $175 on, Wednesday, September 4th, 2024
  • Yaron Werber of "TD Cowen" Maintained at Strong Buy with Decreased Target to $157 on, Wednesday, September 4th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $165 on, Wednesday, September 4th, 2024
  • Kelly Shi of "Jefferies" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, August 13th, 2024
  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $200 on, Friday, May 31st, 2024

Publication Contributing Sources